Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.48
-0.13 (-1.51%)
Nov 25, 2025, 11:37 AM EST - Market open

Ginkgo Bioworks Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
4825213,3342,85612,355-
Upgrade
Market Cap Growth
3.24%-84.36%16.75%-76.89%--
Upgrade
Enterprise Value
4503512,6881,61810,698-
Upgrade
Last Close Price
8.619.8267.6067.60332.40-
Upgrade
PS Ratio
2.612.3013.265.9839.37-
Upgrade
PB Ratio
0.870.733.041.657.88-
Upgrade
P/TBV Ratio
0.980.813.451.838.45-
Upgrade
EV/Sales Ratio
2.491.5410.693.3934.09-
Upgrade
Debt / Equity Ratio
0.760.650.220.260.020.04
Upgrade
Asset Turnover
0.140.150.120.210.230.11
Upgrade
Inventory Turnover
---51.9020.30-
Upgrade
Quick Ratio
4.205.455.878.0912.515.50
Upgrade
Current Ratio
4.395.626.118.3812.795.83
Upgrade
Return on Equity (ROE)
-50.02%-60.34%-63.02%-127.52%-180.29%-26.08%
Upgrade
Return on Assets (ROA)
-15.55%-19.67%-21.82%-59.17%-83.23%-12.48%
Upgrade
Return on Capital (ROIC)
-18.65%-23.74%-26.09%-72.37%-110.02%-17.02%
Upgrade
Return on Capital Employed (ROCE)
-30.90%-37.70%-48.90%-92.20%-94.40%-22.80%
Upgrade
Earnings Yield
-69.39%-104.94%-26.78%-73.72%-14.81%-
Upgrade
FCF Yield
-38.25%-73.31%-10.09%-10.66%-2.51%-
Upgrade
Buyback Yield / Dilution
-7.58%-6.76%-15.75%-23.48%-6.71%-10.95%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q